Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

In vitro and in vivo chondrogenic performance of κ-carrageenan/silk fibroin bioinks containing ADMSCs-seeded microcarriers for auricular cartilage regeneration.

Akbayrak SK., Çayır Ü., Boynuyoğun E., Yavaş E., Gümüşderelioğlu M., Çaylı S.

Animal Study on Cartilage Damage, published in Int J Biol Macromol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Biol Macromol (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
42595150
DOI
10.1016/j.ijbiomac.2026.154009

Abstract (original English)

Elastic cartilage is essential for preserving the structural integrity and functional flexibility of tissues such as the auricle and epiglottis. However, its limited capacity for self-repair poses significant challenges in the treatment of injuries resulting from trauma, congenital defects, or disease. This study investigates the in vitro and in vivo regenerative potential of a bioink designed for auricular cartilage repair. The primary polymeric components of the bioink were κ-carrageenan and silk fibroin (κ-CA/SF), while the cellular component consisted of adipose-derived stem cells (ADMSCs) isolated from rabbits, which were subsequently seeded onto poly(butylene adipate-co-terephthalate) (PBAT) microcarriers. These components were successfully printed utilizing an extrusion-based bioprinter. In vitro analyses demonstrated that ADMSCs were effectively encapsulated within the bioink, maintaining their viability for a duration of 21 days. Quantitative RT-qPCR analyses confirmed the expression of COL2A1, the major structural protein of cartilage and a critical indicator of the chondrocyte phenotype; its expression was observed to be approximately 35-fold higher in the κ-CA/SF + PBAT group compared to the κ-CA/SF group (***p < 0.001). Additionally, the presence of collagen II and aggrecan within the constructs was confirmed through immunostaining. For in vivo experiments, a circu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research